• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY Back to Search Results
Model Number 610-0001
Device Problems Contamination (1120); Labelling, Instructions for Use or Training Problem (1318)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/15/2016
Event Type  Injury  
Manufacturer Narrative
The device history record for this manufacturing lot was reviewed and the device met all release criteria and there were no discrepancies or unusual findings that relate to the reported event.The explanted inlay has not been received at this time.Please reference the attached medication alert for durezol.Complaint reference number: (b)(4).
 
Event Description
The patient underwent implantation of the raindrop corneal inlay in the left eye.During surgery, durezol was instilled and then the corneal flap was re-lifted several times in an attempt to optimize flap positioning.During the same day examinations (day 0), debris was observed in the interface.The patient was monitored throughout the early postoperative period and there was no progression, but no improvement.The interface debris was suspected to be residual durezol.The inlay was explanted six days postoperatively and the interface was irrigated copiously with balanced salt solution.Additional information is being requested.
 
Manufacturer Narrative
The explanted inlay was returned to the manufacturer and subjected to visual microscopic inspection analysis.Several dark and light, in color, particulates were observed on the device.Since these findings are consistent with the findings for corneal inlays that have been explanted, it could not be determined if the particulates were remains of durezol as suspected in the reported complaint information.The particulates observed are similar to what is expected for the handling of explanted inlays.Complaint reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAINDROP NEAR VISION INLAY
Type of Device
CORNEAL INLAY
Manufacturer (Section D)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer (Section G)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer Contact
pushpita singh
25651 atlantic ocean dr.,
ste. a1
lake forest, CA 92630-8835
9497072740
MDR Report Key6251962
MDR Text Key64889834
Report Number3005956347-2017-00006
Device Sequence Number1
Product Code LQE
UDI-Device Identifier10850394006013
UDI-Public(01)10850394006013(17)190913(10)002990
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date 08/31/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/13/2019
Device Model Number610-0001
Device Catalogue NumberRD1-1
Device Lot Number002990
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/13/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/25/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/13/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number3005956347-02/03/17-001
Patient Sequence Number1
Treatment
DUREZOL; FEMTOSECOND LASER FOR CREATION OF CORNEAL FLAP
Patient Outcome(s) Required Intervention;
Patient Age50 YR
-
-